Quantcast
Mimicking Natural Evolution With Promiscuous Reactions To

Mimicking Natural Evolution With 'Promiscuous Reactions' To Improve The Diversity Of Drugs

Sarah Reed, University of Leeds A revolutionary new scientific method developed at the University of Leeds will improve the diversity of ‘biologically active molecules’, such as antibiotics and anti-cancer agents. The researchers, who...

Latest Clinical research Stories

2014-08-29 23:09:31

On August 26, the FDA announced the recall of several sterile convenience surgical packs, by Customed Inc., due to possible loss of sterility. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) August 29, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on sterile convenience surgical packs. The US FDA...

2014-08-29 20:21:53

NEW YORK, Aug. 29, 2014 /PRNewswire/ -- Pomerantz LLP has filed a class action lawsuit against EDAP TMS S.A. ("EDAP" or the "Company") (NASDAQ: EDAP) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 14-cv-6069, is on behalf of a class consisting of all persons or entities who purchased EDAP securities between February 1, 2013 and July 30, 2014, inclusive (the "Class Period"). This class action...

2014-08-29 16:24:04

-- Clinical and preclinical programs remain on track SAN DIEGO, Aug. 29, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), an emerging biopharmaceutical company, announced today that Santosh Vetticaden, Chief Medical Officer and Senior Vice President, will be leaving the Company, for personal reasons, in mid-September. Edwin L. Parsley, D.O., the Chief Medical Officer of Aires Pharmaceuticals, which Mast acquired earlier this year, will assume Dr. Vetticaden's former...

2014-08-28 23:15:55

For 30 years, devicemakers have relied on The GMP Letter for the latest on the FDA's interpretation and enforcement of cGMPs and Quality Systems Regulation, information readers need to stay in compliance. Each monthly issue brings its readers updates on the FDA’s approach to facility inspections, changes to the EU’s unannounced inspections and the latest on joint inspections in these and other jurisdictions. Falls Church, VA (PRWEB) August 28, 2014 Subscribe to The GMP Letter...

2014-08-28 23:15:08

On August 1, New England Greens, LLC dba Vibrant Health announced that specific lots of Green Vibrance and one lot of Rainbow Vibrance are recalled because of possible health risk. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) August 28, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Green Vibrance...

2014-08-28 23:07:25

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Kristen DeVito, Global Director Clinical Supply Services, and Chris Greco, Manager, Comparator and Ancillary Supplies, will present “Critical Path Sourcing Strategies for Active Control Clinical Trials” at the forthcoming US Clinical Trials Supply Conference, which takes place on the 9th – 10th...

2014-08-28 23:03:32

Pall Life Sciences signs on as a program sponsor of the 2014 BioProcess International Awards, which will be presented October 22, 2014 in Boston, MA. New York, NY (PRWEB) August 28, 2014 BioProcess International (BPI), a business-to-business publication dedicated to delivering cutting-edge information focused on the development and manufacture of biopharmaceuticals and therapeutics, announces an agreement with Pall Life Sciences to become a program sponsor of the 2014 BioProcess...

2014-08-28 12:29:56

PITTSBURGH, Aug. 28, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its abbreviated new drug application (ANDA) for a three times per week Glatiramer Acetate Injection 40 mg/mL has been accepted for filing by the U.S. Food and Drug Administration (FDA). This product is the generic version of Teva's Copaxone® 40 mg/mL, which is indicated for the treatment of patients with relapsing forms of multiple sclerosis (MS)....

2014-08-28 12:29:50

Ribbon-Cutting Ceremony Scheduled for September 3, 2014 ROCKVILLE, Md., Aug. 28, 2014 /PRNewswire/ -- Tasly Pharmaceuticals, Inc., a global leader in Pharmaceuticals, Biologics, and Nutraceuticals, will hold a ribbon-cutting ceremony on September 3, 2014, in Tasly's corporate offices in Rockville, MD. The ceremony will mark the official launch of Tasly Pharmaceuticals, Inc. as the North American headquarters of Tasly Holding Group, a global technology company established in China...

2014-08-28 08:27:37

-- Fujifilm's pAVEway(TM) Platform Demonstrated >25-fold Improvement in SYN-004 Expression Titers -- ROCKVILLE, Md., Aug. 28, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, and FUJIFILM Diosynth Biotechnologies UK Limited (Fujifilm), announced today confirmation of exceptional results from the initial phase of cGMP manufacturing of...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related